| # | Drug | Count |
|---|---|---|
| 0 | CYTARABINE | 2 |
| 1 | ETOPOSIDE | 2 |
| 2 | RITUXIMAB | 2 |
| 3 | ACYCLOVIR | 1 |
| 4 | CEFTRIAXONE | 1 |
| 5 | CEFTRIAXONE SODIUM | 1 |
| 6 | CHOLESTYRAMINE | 1 |
| 7 | ETANERCEPT | 1 |
| 8 | FLUCONAZOLE | 1 |
| 9 | GEMTUZUMAB OZOGAMICIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 1 | GEMTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 2 | CHOLESTYRAMINE | 1 | 0.0001 |
| 3 | MELPHALAN HYDROCHLORIDE | 1 | 0.0000 |
| 4 | CYTARABINE | 2 | 0.0000 |
| 5 | RISEDRONATE SODIUM | 1 | 0.0000 |
| 6 | ETOPOSIDE | 2 | 0.0000 |
| 7 | CEFTRIAXONE SODIUM | 1 | 0.0000 |
| 8 | FLUCONAZOLE | 1 | 0.0000 |
| 9 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 1 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 2 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 4 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |